Log in to search using one of your social media accounts:

New Drug OK'd for Hereditary Angioedema
(MedPage Today) -- First subcutaneous C1 esterase inhibitor approved for HAE prophylaxis (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - June 23, 2017 Category: Allergy & Immunology Source Type: news

1991 - 2014 Saw Minimal Change in Health Spending Per State
Recession and recovery, implementation of health reform impacted health care coverage (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - June 23, 2017 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Lone Star ticks can cause people to be allergic to meat
A bite from a Lone Star tick (pictured) can cause people to be allergic to meat.  The bug is typically found in the southeast but has spread to the Midwest and northeast. (Source: the Mail online | Health)
Source: the Mail online | Health - June 22, 2017 Category: Consumer Health News Source Type: news

Mylan shareholders vote against executive pay, re-elect board
AMSTERDAM (Reuters) - Mylan NV shareholders voted against the generic drugmaker's executive pay policy but re-elected the board at its annual meeting on Thursday despite a shareholder campaign in the wake of a scandal over high prices for its EpiPen emergency allergy treatment. (Source: Reuters: Health)
Source: Reuters: Health - June 22, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Mylan shareholders re-elect board, vote against executive pay
AMSTERDAM (Reuters) - Mylan NV shareholders re-elected the generic drugmaker's board at its annual meeting on Thursday, despite a shareholder campaign to vote down most of the directors in the wake of a scandal related to its high prices for emergency allergy treatment EpiPen. (Source: Reuters: Health)
Source: Reuters: Health - June 22, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Science: Working at the speed of emerging technologies
FDA Acting Chief Scientist Luciana Borio By Luciana Borio, M.D. Let’s face it, we’ve all gotten used to nearly instant access to almost anything. Today, with a tap of an app, we order a car ride, a book, or pizza for dinner. Need to navigate past traffic in downtown city streets? No problem. There’s an app for that, too. Some may wonder: Why hasn’t rapid medical product development partaken of this need for speed that has reshaped other sectors of our economy? Well, in many ways, it has. Innovation is happening extraordinarily fast in the biomedical sciences and at FDA. As FDA’s Acting Chief S...
Source: Mass Device - June 22, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Blog FDA Voice Source Type: news

Medical News Today: Yellow jacket stings: What to do
Often mistaken for bees, yellow jackets sting when they feel threatened and can cause an allergic reaction. Learn how to identify the signs and symptoms. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 22, 2017 Category: Consumer Health News Tags: Allergy Source Type: news

Eating more fish 'can alleviate rheumatoid arthritis symptoms'
This study indicates that simple changes, such as increasing the amount of fish in their diets, could have a big impact on making the condition more manageable. Lead author Dr Sara Tedeschi, of the division of rheumatology, immunology and allergy at Brigham and Women's Hospital and Harvard Medical School, said:"If our finding holds up in other studies, it suggests that fish consumption may lower inflammation related to rheumatoid arthritis disease activity. "Fish consumption has been noted to have many beneficial health effects, and our findings may give patients with rheumatoid arthritis a strong reason to i...
Source: Arthritis Research UK - June 21, 2017 Category: Rheumatology Source Type: news

FDA Approves New, Cheaper Rival to EpiPen Allergy Shot
There are now several cheaper alternatives to the exorbitantly priced EpiPens that should please EMS agencies. ABC News has shared this story:   U.S. regulators have approved new competition for EpiPen, the emergency allergy medicine that made Mylan a poster child for pharmaceutical company greed. The Food and Drug Administration on Thursday approved Adamis Pharmaceuticals Corp.'s product, which should go on sale later this year. Read more... This month’s cover story on the King County Washington EMS system (click here for a link to the article) focuses on their system’s move away from Mylan’s exorb...
Source: JEMS: Journal of Emergency Medical Services News - June 21, 2017 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT P Tags: Patient Care News Source Type: news

FDA Approves New, Cheaper Rival to EpiPen Allergy Shot
There are now several cheaper alternatives to the exorbitantly priced EpiPens that should please EMS agencies. ABC News has shared this story:   U.S. regulators have approved new competition for EpiPen, the emergency allergy medicine that made Mylan a poster child for pharmaceutical company greed. The Food and Drug Administration on Thursday approved Adamis Pharmaceuticals Corp.'s product, which should go on sale later this year. Read more... This month’s cover story on the King County Washington EMS system (click here for a link to the article) focuses on their system’s move away from Mylan’s exorb...
Source: JEMS Patient Care - June 21, 2017 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT P Tags: Patient Care News Source Type: news

Chicago Blackhawks player is allergic to the team's kit
Marian Hossa, a hockey player for the Chicago Blackhawks, said he won't be playing next season due to  a progressive skin condition. The disorder makes him allergic to his hockey equipment. (Source: the Mail online | Health)
Source: the Mail online | Health - June 21, 2017 Category: Consumer Health News Source Type: news

High-fat diet leads to same intestinal inflammation as a virus
FINDINGSA new study by scientists at UCLA found that when mice eat a high-fat diet, the cells in their small intestines respond the same way they do to a viral infection, turning up production of certain immune molecules and causing inflammation throughout the body. The scientists also found that feeding the mice tomatoes containing a protein similar to that in HDL, or “good cholesterol,” along with the generic cholesterol drug Ezetimibe, reversed the inflammation.The results could lead to new types of drugs, targeting the intestinal cells, to reduce people ’s risk of heart attacks and strokes, or to trea...
Source: UCLA Newsroom: Health Sciences - June 21, 2017 Category: Universities & Medical Training Source Type: news

Study pinpoints protein key to fighting a common intestinal illness
Rotavirus is the most common cause of diarrhea in infants and young children worldwide. It is highly infectious and potentially deadly. The virus, which has evolved strategies to evade the immune system, is the focus of new research lead by immunologist Richard Flavell and published in Nature. (Source: Yale Science and Health News)
Source: Yale Science and Health News - June 21, 2017 Category: Universities & Medical Training Tags: Yale News Source Type: news

Drugmaker Mylan gets boost from unlikely source: coal
NEW YORK (Reuters) - Mylan N.V. is best known for producing EpiPen emergency allergy treatments and generic drugs. (Source: Reuters: Health)
Source: Reuters: Health - June 21, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

JFC International Inc. Issues Missing English Label and Allergy Alert on Undeclared Wheat, Soybean, and Fish (Bonito) in Futaba Sesame Hijiki Rice Seasoning
JFC International Inc. of Los Angeles, CA is voluntarily recalling a rice seasoning product because it was found to be missing the English Product Label for sale in the United States. In addition, due to the missing English label, the product has undeclared Wheat, Soybean, and Fish (Bonito) allergens. People who have allergies to wheat, soybeans, or fish (bonito) run the risk of a serious life-threatening allergic reaction if they consume the product. No illnesses have been reported to date in connection with this problem. (Source: Food and Drug Administration)
Source: Food and Drug Administration - June 21, 2017 Category: Food Science Source Type: news

Batch of Fat Cat Purry-Purry Sauce Hot Sauce Recalled Due to Undeclared Allergens in Per-Peri Pepper Ingredient
A single production batch of Fat Cat Purry-Purry Sauce Hot Sauce, sold specifically to Winn-Dixie Supermarkets, BI-LO Supermarkets and Harvey ’s Supermarkets in the Southeastern U.S., has been recalled due to a potential peanut contamination found in the product. People who have allergies to peanuts run the risk of serious or life-threatening allergic reaction if they consume this product. (Source: Food and Drug Administration)
Source: Food and Drug Administration - June 20, 2017 Category: Food Science Source Type: news

Oh, Lovely: The Tick That Gives People Meat Allergies Is Spreading
By Megan Molteni for WIRED. First comes the unscratchable itching, and the angry blossoming of hives. Then stomach cramping, and — for the unluckiest few — difficulty breathing, passing out, and even death. In the last decade and a half, thousands of previously protein-loving Americans have developed a dangerous allergy to meat. And they all have one thing in common: the lone star tick. Red meat, you might be surprised to know, isn’t totally sugar-free. It contains a few protein-linked saccharides, including one called galactose-alpha-1,3-galactose, or alpha-gal, for short. More and more people are lear...
Source: Healthy Living - The Huffington Post - June 20, 2017 Category: Consumer Health News Source Type: news

Support for Financial Penalties Up With Emphasis on Patient Harms
Penalties supported by 41 % of physician recipients of clinical vignette describing harms to patient (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - June 20, 2017 Category: Respiratory Medicine Tags: Family Medicine, Geriatrics, Gynecology, Infections, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nursing, ENT, Pharmacy, Pulmonology, Surgery, Urology, Journal, Source Type: news

Report: Apple partners with Health Gorilla to integrate iPhone with hospital, lab data
Apple (NSDQ:AAPL) is working with medtech startup Health Gorilla to add more health info, including diagnostic lab data, to its iPhone as it continues its quest to make it a centralized location for medical data, according to a CNBC report. The tech giant is working with the startup to integrate information from hospitals, lab-testing companies and imaging centers into the device, according to the report. Health Gorilla, which rebranded from Informedika in 2014, has raised a total of $4.4 million to support its clinical network platform. The company’s platform is a closed, HIPAA-compliant system which allows doc...
Source: Mass Device - June 20, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Electronic Medical Records Health Information Technology Software / IT Apple healthgorilla Source Type: news

Penn immunologist selected as Pew Scholar in Biomedical Sciences
(University of Pennsylvania School of Medicine) Jorge Henao-Mejia, M.D., Ph.D., an assistant professor of Pathology and Laboratory Medicine in the Perelman School of Medicine at the University of Pennsylvania and Children ’ s Hospital of Philadelphia, has been recognized by The Pew Charitable Trusts as one of its 22 national Pew Scholars in Biomedical Sciences. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 20, 2017 Category: International Medicine & Public Health Source Type: news

EC approves Sandoz ’s Rixathon for blood cancer and immunological diseases
Novartis division Sandoz ’s Rixathon (biosimilar rituximab) has received approval from the European Commission (EC) to treat blood cancers and immunological diseases in Europe. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - June 19, 2017 Category: Pharmaceuticals Source Type: news

iMedicalApps: This Week's Top iOS Apps
(MedPage Today) -- Pulmonology, plastic surgery, and allergy apps top the list (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - June 19, 2017 Category: Respiratory Medicine Source Type: news

Gluten intolerance may be wildly over-diagnosed, warns nutritionist
(Natural News) Listen up: You are more likely to experience allergic reactions from eating fruits and vegetables than gluten, according to a paper published in the Clinical & Experimental Allergy. Although many claim that they’re allergic to gluten, the study showed that only one percent of people actually have a reaction to wheat compared to... (Source: NaturalNews.com)
Source: NaturalNews.com - June 19, 2017 Category: Consumer Health News Source Type: news

Experts Cautious About Food Diversity to Avert Allergy Experts Cautious About Food Diversity to Avert Allergy
Despite evidence suggesting that exposure to different food types introduced early in childhood protects against allergic diseases, researchers say it is too early to make recommendations.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 19, 2017 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news

PerkinElmer to buy Euroimmun in $1.3B deal
PerkinElmer (NYSE:PKI) inked a deal today to acquire Euroimmun Medical Laboratory Diagnostics for $1.3 billion in cash. The move is an effort to expand into autoimmune and allergy diagnostic markets, according to the scientific instruments-maker. Germany-based Euroimmun has 2,400 employees and is expected to bring in $310 million in revenue this year. Get the full story at our sister site, Drug Delivery Business News. The post PerkinElmer to buy Euroimmun in $1.3B deal appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - June 19, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Diagnostics Mergers & Acquisitions Wall Street Beat euroimmun PerkinElmer Inc. Source Type: news

Kabir ’s Bakery issues allergy alert on undeclared milk in “Kabir’s Bakery Cinnamon Twist” and “Kabir’s Bakery Cinnamon Raisin Danish” in four ounce plastic packages, all container codes.
Kabir ’s Bakery of Brooklyn, NY is recalling “Kabir’s Bakery Cinnamon Twist“ and “Kabir’s Bakery Cinnamon Raisin Danish” in four ounce plastic packages, all container codes, due to the presence of undeclared milk. Consumers who are allergic to milk run the risk of serious life threatening a llergic reactions if they consume this product (Source: Food and Drug Administration)
Source: Food and Drug Administration - June 19, 2017 Category: Food Science Source Type: news

Rikki USA, Inc. Issues Allergy Alert on Undeclared Milk in Masa ’s Gourmet Sweet and Sour Sauce, Masa’s Gourmet Curry Coconut Sauce and Masa’s Gourmet Pulled Pork BBQ Sauce
Rikki USA, Inc. of Redmond, WA is recalling Masa ’s Gourmet Sweet and Sour Sauce, Masa’s Gourmet Curry Coconut Sauce and Masa’s Gourmet Pulled Pork BBQ Sauce because it contains undeclared milk. People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they consume these product s. (Source: Food and Drug Administration)
Source: Food and Drug Administration - June 19, 2017 Category: Food Science Source Type: news

PBL Gains Approval to Advance Next Generation Anthrax Vaccine
Porton Biopharma Ltd (PBL) has announced that it has signed a modification to its contract with the US National Institute of Health's National Institute of Allergy and Infectious Diseases (NIAID) to advance a next generation intra-nasal anthrax vacci … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - June 19, 2017 Category: Pharmaceuticals Source Type: news

New patient survey highlights need for more action to help severe asthma patients gain control of their disease
Novartis announced the results of a new survey of 904 severe asthma patients, presented for the first time at the European Academy of Allergy and Clinical Immunology (EAACI) Congress[1]. Data from the 'Still Fighting for Breath' survey demonstrate that, despite the widespread availability of oral and inhaled treatments, asthma still places a huge burden on the personal and professional lives of those living with the disease in Europe. (Source: World Pharma News)
Source: World Pharma News - June 19, 2017 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news

Novartis throws down gauntlet to Roche with Rituxan copy
ZURICH (Reuters) - Switzerland's Novartis increased pressure on Roche's ageing stable of big-selling drugs on Monday by becoming the latest company to win European approval for a cut-price version of Rituxan for blood cancer and immunological diseases. (Source: Reuters: Health)
Source: Reuters: Health - June 19, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

New EpiPen Competitor Approved by FDA
Title: New EpiPen Competitor Approved by FDACategory: Health NewsCreated: 6/16/2017 12:00:00 AMLast Editorial Review: 6/19/2017 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - June 19, 2017 Category: Allergy & Immunology Source Type: news

Novartis wins European approval for biosimilar version of Roche's MabThera
ZURICH (Reuters) - Swiss drugmaker Novartis on Monday said it had won European approval for its biosimilar version of Roche's blockbuster Rituxan as the crosstown rivals go head-to-head on a drug to treat blood cancers and immunological diseases. (Source: Reuters: Health)
Source: Reuters: Health - June 19, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Scientists identify single-gene mutations that lead to atopic dermatitis
(NIH/National Institute of Allergy and Infectious Diseases) Researchers have identified mutations in a gene called CARD11 that lead to atopic dermatitis, or eczema, an allergic skin disease. Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and other institutions discovered the mutations in four unrelated families with severe atopic dermatitis and studied the resulting cell-signaling defects that contribute to allergic disease. Their findings also suggest that some of these defects potentially could be corrected by supplementation with the amino ac...
Source: EurekAlert! - Medicine and Health - June 19, 2017 Category: International Medicine & Public Health Source Type: news

Tumor immune fitness determines survival of lung cancer patients
(La Jolla Institute for Allergy and Immunology) In recent years, immunotherapy, a new form of cancer therapy that rouses the immune system to attack tumor cells, has captivated the public's imagination. When it works, the results are breathtaking. But more often than not it doesn't, and scientists still don't know why. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 19, 2017 Category: Cancer & Oncology Source Type: news

Link Between Asthma, Type 1 Diabetes Hangs on Which Comes First Link Between Asthma, Type 1 Diabetes Hangs on Which Comes First
The association between the development of asthma and the development of type 1 diabetes depends on which disease occurs first, a large case-cohort study shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 18, 2017 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news

FDA Approves New Epinephrine Injector for Anaphylaxis
(MedPage Today) -- Symjepi is latest alternative to EpiPen (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - June 17, 2017 Category: Allergy & Immunology Source Type: news

Billionaire Koch brother donates $10M to Stanford children's hospital to back allergy research
Koch Industries executive David Koch and his wife have donated $10 million to advance allergy research at Stanford. The funding will allow researchers to grow the team at its new campus and run more clinical trials. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 17, 2017 Category: American Health Authors: Antoinette Siu Source Type: news

Health Insurers Recruiting Former Pharma Reps to Cut Costs
Former pharma reps are educating doctors about costs of meds, encouraging use of generics (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 17, 2017 Category: Cancer & Oncology Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Nephrology, Neurology, Oncology, Ophthalmology, Orthopedics, ENT, Pediatrics, Pharmacy, Psychiatry, Pulmonolog Source Type: news

Billionaire Koch brother donates $10M to Stanford children's hospital to back allergy research
Koch Industries executive David Koch and his wife have donated $10 million to advance allergy research at Stanford. The funding will allow researchers to grow the team at its new campus and run more clinical trials. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 16, 2017 Category: Biotechnology Authors: Antoinette Siu Source Type: news

Billionaire Koch brother donates $10M to Stanford children's hospital to back allergy research
Koch Industries executive David Koch and his wife have donated $10 million to advance allergy research at Stanford. The funding will allow researchers to grow the team at its new campus and run more clinical trials. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - June 16, 2017 Category: Health Management Authors: Antoinette Siu Source Type: news

Is a new flu pandemic just three mutations away?
Conclusion This laboratory study analysed an H7N9 strain of bird flu. Researchers wanted to explore whether a particular change to the surface proteins of a virus was capable of allowing the strain to bind to human tissue. This would theoretically lead to human-to-human transmission of the flu virus. It is worth noting that this ability to attach to human cells does not necessarily mean a mutated bird flu virus will be able to infect, replicate and transmit between humans. Other changes would also be required. However, they were unable to further investigate whether this surface change could lead to human-to-human transmis...
Source: NHS News Feed - June 16, 2017 Category: Consumer Health News Tags: Heart/lungs Medical practice Source Type: news

FDA approves new, cheaper rival to EpiPen allergy shot
U.S. regulators have approved new competition for EpiPen, the emergency allergy medicine that made Mylan a poster child for pharmaceutical company greed. (Source: the Mail online | Health)
Source: the Mail online | Health - June 16, 2017 Category: Consumer Health News Source Type: news

FDA Approves New Epinephrine Prefilled Syringe FDA Approves New Epinephrine Prefilled Syringe
Symjepi, from Adamis Pharmaceuticals, is for the emergency treatment of type I allergic reactions, including anaphylaxis.FDA Approvals (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - June 16, 2017 Category: Emergency Medicine Tags: Allergy & Clinical Immunology News Alert Source Type: news

Apple looks to make the iPhone a health databank, rumored to be eyeing Athenahealth buy
Apple (NSDQ:AAPL) is looking to make more waves in healthcare by turning its iPhone into a databank of medical data as it eyes a possible acquisition of Athenahealth, according to 2 CNBC reports. The tech-sector giant has reportedly been in talks with players in the healthcare industry and developers to try and bring clinical data, including lab results, allergies, prescriptions and other information, to the iPhone. Users with data on their phone would be able to share it with 3rd parties, including hospitals and health developers, according to CNBC. Apple is reportedly looking at cloud hosting start-ups for potential...
Source: Mass Device - June 16, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Electronic Medical Records Health Information Technology Apple Athenahealth Inc. newtag Source Type: news

Adamis up, Mylan down on generic EpiPen approval
Shares in Adamis Pharmaceuticals (NSDQ:ADMP) soared more than 50% yesterday after it won FDA approval for its generic EpiPen emergency allergy pre-filled syringe, sending shares in competitor Mylan (NSDQ:MYL) down -3%. For years, Mylan has commanded more than 90% of the market for emergency epinephrine injectors. Get the full story at our sister site, Drug Delivery Business News. The post Adamis up, Mylan down on generic EpiPen approval appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - June 16, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Pharmaceuticals Wall Street Beat adamispharmaceuticals Impax Laboratories Mylan Source Type: news

Lower-cost alternative to EpiPen OK ’d by FDA
EpiPen ’s maker sparked huge controversy when it hiked prices of the emergency allergy med through the roof (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - June 16, 2017 Category: Consumer Health News Source Type: news

New EpiPen Competitor Approved by FDA
Title: New EpiPen Competitor Approved by FDACategory: Health NewsCreated: 6/16/2017 12:00:00 AMLast Editorial Review: 6/16/2017 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - June 16, 2017 Category: Allergy & Immunology Source Type: news

AMA Endeavors to Increase Transparency of Rx Pricing
At annual meeting, the physicians'group adopted new policies on drug pricing to protect patients (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - June 16, 2017 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Pediatrics, Pha Source Type: news

Adamis wins U.S. approval to sell EpiPen rival, shares soar
(Reuters) - Adamis Pharmaceuticals Corp said on Thursday it received U.S. approval for its emergency epinephrine syringes to treat severe allergic reactions that would compete with Mylan NV's widely used EpiPen, sending its shares up more than 50 percent. (Source: Reuters: Health)
Source: Reuters: Health - June 15, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

FDA approves new, cheaper rival to EpiPen allergy shot
U.S. regulators approve new, cheaper competition for EpiPens, the emergency allergy injector that made Mylan a poster child for pharmaceutical company greed (Source: ABC News: Health)
Source: ABC News: Health - June 15, 2017 Category: Consumer Health News Tags: Health Source Type: news